SECTION I · THE BRIEF
Brief #83194Updated 17 AUG 2026REDWOOD CITY, CALIFORNIA, UNITED STATESGreenhouseMEDICAL ORGANIZATIONS
Employbl Company Profile

Senior Director, Global SOX

Revolution Medicines, Inc. operates as an oncology company. The Company discovers novel targeted therapies to inhibit elusive frontier targets within notorious growth and survival pathways. Revolution Medicines serves…

Location
Redwood City, California, United States
Company size
700–700
Posted
Today
Via
Greenhouse
Section II · Premium ProfileMembers only
  • 01Comp band & equity packageLocked
  • 02Seniority & experience requirementsLocked
  • 03Interview process & rubricLocked
  • 04Hiring manager & team contextLocked
  • 05Growth trajectory in this roleLocked
  • 06Offer & decision timelineLocked

7-day free trial · $25/mo · cancel anytime

REVOLUTION Medicines logo

Senior Director, Global SOX · REVOLUTION Medicines

View company profile
Job title
Senior Director, Global SOX
Job location
Redwood City, California, United States
Job description

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

The Opportunity

RevMed is seeking an experienced, collaborative Senior Director, Global SOX to lead and scale the Company’s Sarbanes-Oxley compliance and internal controls program. This role has enterprise-wide governance responsibility for ICFR, ITGCs, ITACs, automated controls, key reports, and controls supporting evolving business processes, systems, commercial readiness, and global expansion.

As a key Controllership leader, this role partners with functions, auditors, and process owners across the United States, Europe, Japan, Canada, and other markets. The leader will establish global SOX governance and practical regional execution, ensuring rigorous compliance while building risk-based, scalable controls that work effectively with business operations.

This role reports to the VP, Finance, Controller, is based at RevMed’s Redwood City headquarters, and works closely with regional Finance, IT, and business teams.

Responsibilities

Global SOX Program Leadership

  • Lead RevMed’s global SOX and ICFR program, including annual planning, scoping, risk assessments, walkthroughs, documentation, testing coordination, deficiency evaluation, remediation tracking, and reporting.
  • Develop a scalable operating model with centralized governance, consistent standards, clear accountability, and right-sized controls that maintain compliance without unnecessary operational burden.
  • Partner with Accounting, SEC Reporting, Technical Accounting, IT, Commercial, Supply Chain, Legal, HR, and regional teams to identify financial reporting risks and ensure controls are well designed, documented, owned, and effective.
  • Maintain SOX documentation, including risk and control matrices, narratives, flowcharts, key reports, management review controls, and regional certifications or attestations.
  • Provide quarterly and annual SOX updates to the Controller, senior management, and the Audit Committee, including status, key risks, deficiencies, and remediation progress.

ITGC, Systems and Commercial Readiness

  • Lead the global ITGC program for enterprise and regional systems supporting financial reporting, including ERP, procurement, payroll, equity, SEC reporting, lease accounting, commercial, inventory, consolidation, and other in-scope applications.
  • Oversee ITGC domains such as user access, privileged access, change management, SDLC, computer operations, interfaces, data integrity, cybersecurity dependencies, and third-party providers.
  • Partner with IT, Information Security, system owners, and process owners to assess control implications of new systems, integrations, cross-border data flows, and significant configuration changes.
  • Embed controls by design in system implementations, regional deployments, localizations, and significant process changes, including access provisioning, change management, report validation, and post-implementation readiness.
  • Support controls over commercialization and operational processes, including order-to-cash, gross-to-net, revenue recognition, inventory, third-party logistics, distributors / specialty pharmacies, patient support, government pricing / rebates, and country launches.

Auditor Coordination, Remediation and Team Leadership

  • Serve as the global SOX liaison with internal and external auditors, process owners, IT, Information Security, and other stakeholders to support efficient walkthroughs, testing, evidence submission, and issue resolution.
  • Coordinate the global SOX calendar, PBC requests, control-owner responses, audit deliverables, and consolidated status reporting across regions and time zones.
  • Identify audit bottlenecks, documentation gaps, control design issues, testing matters, and opportunities to simplify or automate controls while maintaining compliance and auditability.
  • Lead evaluation and remediation of control observations and deficiencies, including root cause, severity, impact, remediation plans, and validation of operating effectiveness.
  • Build and develop a high-performing global SOX and ITGC function, including employees, regional resources, consultants, and co-sourced providers.

Required Skills, Experience and Education:

  • Bachelor’s degree or higher in Accounting, Finance, Information Systems, Business Administration, or a related field.

  • CPA, CIA, CISA, or equivalent certification strongly preferred; at least one relevant certification expected.

  • 12+ years of progressive experience in SOX, internal controls, IT audit, public accounting, internal audit, controllership, or related fields.

  • Significant experience leading a SOX 404 program for a publicly traded, multi-entity company with international operations.

  • Deep knowledge of SOX 404, COSO, PCAOB auditing standards, SEC reporting requirements, ICFR, management review controls, and financial reporting risk assessment.

  • Strong ITGC and ITAC experience across access, change management, SDLC, computer operations, interfaces, automated controls, key reports, SOC report review, CUECs, and third-party provider controls.

  • Experience supporting global ERP or financial system implementations, upgrades, integrations, or transformations.

  • Strong understanding of close, consolidation, intercompany, foreign currency, SEC reporting, equity, payroll, procurement, AP, treasury, leases, revenue, inventory, and other significant accounting processes.

  • Proven ability to influence cross-functional and cross-cultural stakeholders, drive accountability, and communicate clearly with senior leaders, auditors, control owners, and technical and non-technical audiences.

Preferred Skills:

  • Experience in a global biotech, pharmaceutical, life sciences, or healthcare company preparing for or operating in a commercial-stage environment.

  • Experience with multi-country launch readiness, revenue recognition, gross-to-net, inventory, third-party logistics, government pricing, specialty distributors / pharmacies, or patient support programs.

  • Experience with NetSuite, Coupa, Workday, ADP, equity platforms, Active Disclosure / Workiva, lease and commercial systems, GRC / SOX tools, data warehouses, and reporting platforms.

  • Experience building or scaling an in-house global SOX function, including centralized standards and regional execution.

  • Experience implementing SOX automation, evidence workflows, dashboards, analytics, or AI-enabled monitoring.

  • Public accounting or Big 4 / national firm experience strongly preferred.

#LI-GL1 #LI-Hybrid


We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
 
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
 
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.


 

View job listing ↗

Get the Saturday tech briefing

New company profiles, funding moves, and who’s hiring across the market — every Saturday morning.

REVOLUTION Medicines headquarters

Redwood City, CA

Company size

700700 employees

Founded

2014

Total raised

$4,254,400,102

View company profile ↗

Funding rounds

  • Post Ipo Debt$500M
  • Post Ipo Equity$1.5B
  • Post Ipo Debt$250M
  • Post Ipo Equity$750M
  • Post Ipo Equity$323.6M
  • Post Ipo Equity$264.5M
  • Post Ipo Equity$260.9M
  • Post Ipo Equity$179.4M
  • IPOUndisclosed
  • Series C$100M
  • Series B$56M
  • Series A$25M
  • Series A$45M